Atara Biotherapeutics, Inc.
ATRA
$10.51
$0.292.84%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -1.44% | -38.14% | -38.57% | 61.28% | -67.43% |
| Total Receivables | -- | -34.50% | -- | -- | 498.85% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 53.94% | -11.76% | 14.62% | -45.16% | -56.48% |
| Total Current Assets | -0.32% | -33.75% | -25.59% | -8.87% | -58.11% |
|
|
|||||
| Total Current Assets | -0.32% | -33.75% | -25.59% | -8.87% | -58.11% |
| Net Property, Plant & Equipment | -2.84% | -34.25% | -3.12% | -65.00% | -22.11% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.45% | 0.57% | -4.96% | -67.41% | -8.35% |
| Total Assets | -1.18% | -32.92% | -18.25% | -40.52% | -43.14% |
|
|
|||||
| Total Accounts Payable | 401.57% | -60.06% | -81.95% | 27.31% | -68.31% |
| Total Accrued Expenses | -21.39% | -35.34% | -42.97% | -46.10% | -20.21% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -1.36% | -47.36% | -12.89% | -83.89% | -0.01% |
| Total Finance Division Other Current Liabilities | -86.63% | -2.01% | 564.65% | -89.95% | -83.26% |
| Total Other Current Liabilities | -86.63% | -2.01% | 564.65% | -89.95% | -83.26% |
| Total Current Liabilities | -62.17% | -17.36% | 23.99% | -69.59% | -64.41% |
|
|
|||||
| Total Current Liabilities | -62.17% | -17.36% | 23.99% | -69.59% | -64.41% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -2.90% | -37.71% | -2.73% | -44.96% | -6.31% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 23.56% | 2.16% | -19.58% | 1.85% | -1.67% |
| Total Liabilities | -2.43% | -12.07% | -7.15% | -38.57% | -43.26% |
|
|
|||||
| Common Stock & APIC | 0.27% | 0.08% | 0.14% | 0.90% | 0.22% |
| Retained Earnings | -0.21% | -0.17% | -0.21% | 0.12% | 1.85% |
| Treasury Stock & Other | -- | -50.00% | -- | -- | -- |
| Total Common Equity | 3.09% | -5.10% | -4.55% | 36.37% | 43.39% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 3.09% | -5.10% | -4.55% | 36.37% | 43.39% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 3.09% | -5.10% | -4.55% | 36.37% | 43.39% |
|
|
|||||